EXUBERA Side Effects

6417053-1 | Chest Pain, Dyspnoea
on Mar 29, 2007 Male patient from UNITED KINGDOM , 42 years of age, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), dyspnoea. Exubera dosage: . During the same period patient was treated with PARACETAMOL (View Paracetamol Review and Paracetamol Label ), HUMALOG (View Humalog Review and Humalog Label ).

6374723-1 | Coma, Diabetes Mellitus
Patient was taking Exubera (View Usage). Patient had the following side effects: coma, diabetes mellitus on Sep 24, 2009 from UNITED STATES Additional patient health information: Female patient , weighting 120.0 lb, was diagnosed with diabetes mellitus and. Exubera dosage: Unk. Patient was hospitalized.

6333120-5 | Anaphylactic Shock
Adverse event was reported on Aug 17, 2009 by a Male patient taking Exubera (View Usage) (Dosage: Unk) . Location: UNITED STATES , child 7 years of age, After Exubera was administered, patient had the following side effects: anaphylactic shock.

6251657-4 | Coma, Diabetes Mellitus
on Jun 18, 2009 Female patient from UNITED STATES , weighting 120.0 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: coma, diabetes mellitus. Exubera dosage: Unk. Patient was hospitalized.


6231303-6 | Blood Glucose Increased, Medical Device Complication
on Jun 16, 2009 Male patient from UNITED STATES , weighting 279.9 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: blood glucose increased, medical device complication. Exubera dosage: . During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), GLIBENCLAMIDE (Unk) (View Glibenclamide Review and Glibenclamide Label ), XANAX (View Xanax Review and Xanax Label ), BYETTA (View Byetta Review and Byetta Label ), ALTACE (View Altace Review and Altace Label ), PLAVIX (View Plavix Review and Plavix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ).

6187735-8 | Metastases To Central Nervous System, Pneumonia, Tracheo-oesophageal Fistula
Patient was taking Exubera (View Usage). After Exubera was administered, patient had the following side effects: metastases to central nervous system, pneumonia (What is pneumonia?), tracheo-oesophageal fistula on May 01, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 220.0 lb, was diagnosed with type 2 diabetes mellitus, metastases to bone and. Exubera dosage: . During the same period patient was treated with ANTINEOPLASTIC AGENTS (Unk) (View Antineoplastic Agents Review and Antineoplastic Agents Label ). Patient was hospitalized.

6101638-6 | Lung Neoplasm Malignant
Adverse event was reported on Mar 03, 2009 by a Male patient taking Exubera (View Usage) (Dosage: ) . Location: UNITED STATES , 50 years of age, weighting 200.0 lb, Patient experienced the following unwanted or unexpected effects: lung neoplasm malignant.

6086612-0 | Anaemia, Bladder Obstruction, Clostridial Infection, Dyspnoea, Myocardial Infarction, Pneumonia, Renal Failure, Sleep Apnoea Syndrome, Staphylococcal Infection
on Feb 10, 2009 Male patient from UNITED STATES , weighting 226.0 lb, was diagnosed with diabetes mellitus, depression (What is depression?) and was treated with Exubera (View Usage). Patient had the following side effects: anaemia, bladder obstruction, clostridial infection, dyspnoea, myocardial infarction, pneumonia (What is pneumonia?), renal failure, sleep apnoea syndrome, staphylococcal infection (What is staphylococcal infection?). Exubera dosage: Unk. During the same period patient was treated with LISINOPRIL (Unk) (View Lisinopril Review and Lisinopril Label ), TAMSULOSIN HYDROCHLORIDE (Unk) (View Tamsulosin Hydrochloride Review and Tamsulosin Hydrochloride Label ), TRAZODONE (Unk) (View Trazodone Review and Trazodone Label ), DOXAZOSIN MESILATE (Unk) (View Doxazosin Mesilate Review and Doxazosin Mesilate Label ), NORVASC (Unk) (View Norvasc Review and Norvasc Label ), LASIX (40 Mg, 4x/day) (View Lasix Review and Lasix Label ), GLIPIZIDE (Unk) (View Glipizide Review and Glipizide Label ), METOPROLOL TARTRATE (Unk) (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ). Patient was hospitalized.

6076200-4 | Metastases To Central Nervous System, Pneumonia, Tracheo-oesophageal Fistula
on Feb 12, 2009 Male patient from UNITED STATES , weighting 220.0 lb, was diagnosed with type 2 diabetes mellitus, metastases to bone and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: metastases to central nervous system, pneumonia (What is pneumonia?), tracheo-oesophageal fistula. Exubera dosage: . During the same period patient was treated with ANTINEOPLASTIC AGENTS (Unk) (View Antineoplastic Agents Review and Antineoplastic Agents Label ). Patient was hospitalized.

6066232-4 | Blood Glucose Increased, Medical Device Complication
Patient was taking Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, medical device complication on Jan 27, 2009 from UNITED STATES Additional patient health information: Male patient , weighting 279.9 lb, was diagnosed with diabetes mellitus and. Exubera dosage: . During the same period patient was treated with GLIPIZIDE (View Glipizide Review and Glipizide Label ), GLIBENCLAMIDE (Unk) (View Glibenclamide Review and Glibenclamide Label ), XANAX (View Xanax Review and Xanax Label ), BYETTA (View Byetta Review and Byetta Label ), ALTACE (View Altace Review and Altace Label ), PLAVIX (View Plavix Review and Plavix Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), TRAMADOL HYDROCHLORIDE (View Tramadol Hydrochloride Review and Tramadol Hydrochloride Label ).

6003617-6 | Metastases To Central Nervous System, Pneumonia, Tracheo-oesophageal Fistula
Adverse event was reported on Dec 04, 2008 by a Male patient taking Exubera (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, metastases to bone and. Location: UNITED STATES , weighting 220.0 lb, Patient had the following side effects: metastases to central nervous system, pneumonia (What is pneumonia?), tracheo-oesophageal fistula. During the same period patient was treated with ANTINEOPLASTIC AGENTS (Unk) (View Antineoplastic Agents Review and Antineoplastic Agents Label ). Patient was hospitalized.

5963755-0 | Lung Neoplasm Malignant, Metastasis, Oropharyngeal Pain
on Nov 21, 2008 Male patient from UNITED STATES , 50 years of age, weighting 212.0 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: lung neoplasm malignant, metastasis, oropharyngeal pain. Exubera dosage: Ud:3mg, 1mg (3 In 1 D), Inhalation. During the same period patient was treated with AVANDARYL (GLIMEPIRIDE, ROSIGLITAZONE MALEATE) (View Avandaryl (glimepiride, Rosiglitazone Maleate) Review and Avandaryl (glimepiride, Rosiglitazone Maleate) Label ), GLUCOPHAGE XR (METFORMIN HYDROCHLORIDE) (View Glucophage Xr (metformin Hydrochloride) Review and Glucophage Xr (metformin Hydrochloride) Label ), LANTUS (View Lantus Review and Lantus Label ), ZETIA (View Zetia Review and Zetia Label ), MICARDIS (View Micardis Review and Micardis Label ), WELCHOL (View Welchol Review and Welchol Label ), TRICOR (View Tricor Review and Tricor Label ), CRESTOR (View Crestor Review and Crestor Label ).

5947352-9 | Cardiac Failure Congestive
on Oct 30, 2008 Female patient from UNITED STATES , weighting 160.9 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: cardiac failure congestive. Exubera dosage: Daily Dose:7mg-text:tdd: 1 Mg Qd/3 Mg Bid. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ZETIA (View Zetia Review and Zetia Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LASIX (View Lasix Review and Lasix Label ), LUNESTA (View Lunesta Review and Lunesta Label ). Patient was hospitalized.

5937937-8 | Abdominal Pain Upper, Blood Cholesterol Increased, Blood Glucose Increased, Chest Discomfort, Cough, Dyspnoea, Influenza, Rash Erythematous, Swelling
Patient was taking Exubera (View Usage). Patient had the following side effects: abdominal pain upper, blood cholesterol increased, blood glucose increased, chest discomfort, cough, dyspnoea, influenza, rash erythematous, swelling on Oct 23, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 182.1 lb, was diagnosed with type 2 diabetes mellitus, blood cholesterol increased, panic disorder (What is panic disorder?) and. Exubera dosage: . During the same period patient was treated with LIPITOR (View Lipitor Review and Lipitor Label ), TRANXENE (View Tranxene Review and Tranxene Label ), EFFEXOR (View Effexor Review and Effexor Label ), PLAVIX (View Plavix Review and Plavix Label ), LANTUS (View Lantus Review and Lantus Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ).

5924264-8 | Cardiac Failure Congestive
Adverse event was reported on Oct 14, 2008 by a Female patient taking Exubera (View Usage) (Dosage: Daily Dose:7mg-text:tdd: 1 Mg Qd/3 Mg Bid) . Location: UNITED STATES , weighting 160.9 lb, After Exubera was administered, patient had the following side effects: cardiac failure congestive. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), ZETIA (View Zetia Review and Zetia Label ), PROPRANOLOL (View Propranolol Review and Propranolol Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), LASIX (View Lasix Review and Lasix Label ), LUNESTA (View Lunesta Review and Lunesta Label ). Patient was hospitalized.

5916733-1 | Lung Neoplasm
on Oct 08, 2008 Male patient from UNITED STATES , weighting 182.1 lb, was diagnosed with type 1 diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: lung neoplasm. Exubera dosage: Daily Dose:20mg-text:7mg (ac B); 6mg (ac L); 7mg (ac D). During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5907866-4 | Renal Failure Chronic
on Sep 23, 2008 Male patient from GERMANY , weighting 154.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: renal failure chronic. Exubera dosage: . During the same period patient was treated with FUROSEMID (View Furosemid Review and Furosemid Label ), CLONISTADA (View Clonistada Review and Clonistada Label ), MOXONIDINE (View Moxonidine Review and Moxonidine Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), NEXIUM (View Nexium Review and Nexium Label ), VITAMIN A+D (View Vitamin A+d Review and Vitamin A+d Label ). Patient was hospitalized.

5890003-2 | Blood Glucose Increased, Chest Discomfort, Dyspnoea, Rash Erythematous, Swelling, Weight Increased
Patient was taking Exubera (View Usage). After Exubera was administered, patient had the following side effects: blood glucose increased, chest discomfort, dyspnoea, rash erythematous, swelling, weight increased on Sep 12, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 170.4 lb, was diagnosed with type 2 diabetes mellitus, panic disorder (What is panic disorder?) and. Exubera dosage: . During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), EFFEXOR (View Effexor Review and Effexor Label ), PLAVIX (View Plavix Review and Plavix Label ), LANTUS (View Lantus Review and Lantus Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5869856-X | Blood Glucose Increased, Chest Discomfort, Dyspnoea, Joint Swelling, Rash Erythematous, Weight Increased
Adverse event was reported on Aug 28, 2008 by a Female patient taking Exubera (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, panic disorder (What is panic disorder?) and. Location: UNITED STATES , weighting 170.4 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, chest discomfort, dyspnoea, joint swelling, rash erythematous, weight increased. During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), EFFEXOR (View Effexor Review and Effexor Label ), PLAVIX (View Plavix Review and Plavix Label ), LANTUS (View Lantus Review and Lantus Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5851883-X | Blood Glucose Fluctuation
on Jun 13, 2008 Female patient from BELGIUM , weighting 119.0 lb, was diagnosed with hernia (What is hernia?) and was treated with Exubera (View Usage). Patient had the following side effects: blood glucose fluctuation. Exubera dosage: . During the same period patient was treated with CORTISONE (View Cortisone Review and Cortisone Label ). Patient was hospitalized.

5837383-1 | Lung Neoplasm
on Jul 28, 2008 Male patient from UNITED STATES , weighting 182.1 lb, was diagnosed with type 1 diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: lung neoplasm. Exubera dosage: Daily Dose:20mg-text:7mg (ac B); 6mg (ac L); 7mg (ac D). During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5826197-4 | Lung Neoplasm
Patient was taking Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: lung neoplasm on Jul 21, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 182.1 lb, was diagnosed with type 1 diabetes mellitus and. Exubera dosage: Daily Dose:20mg-text:7mg (ac B); 6mg (ac L); 7mg (ac D)-freq:interval: Qd. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5823531-6 | Cough, Diabetes Mellitus Inadequate Control, Glycosylated Haemoglobin Increased
Adverse event was reported on Jul 14, 2008 by a Female patient taking Exubera (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus and. Location: UNITED STATES , weighting 190.0 lb, Patient had the following side effects: cough, diabetes mellitus inadequate control, glycosylated haemoglobin increased. During the same period patient was treated with INSULIN DETEMIR (View Insulin Detemir Review and Insulin Detemir Label ).

5816645-8 | Lung Neoplasm
on Jul 14, 2008 Male patient from UNITED STATES , weighting 182.1 lb, was diagnosed with type 1 diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: lung neoplasm. Exubera dosage: Daily Dose:20mg-text:7mg (ac B); 6mg (ac L); 7mg (ac D). During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5809161-0 | Lung Neoplasm
on Jul 02, 2008 Male patient from UNITED STATES , weighting 182.1 lb, was diagnosed with type 1 diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: lung neoplasm. Exubera dosage: Daily Dose:20mg-text:7mg (ac B); 6mg (ac L); 7mg (ac D). During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5802292-0 | Coronary Artery Disease, Panic Attack
Patient was taking Exubera (View Usage). Patient had the following side effects: coronary artery disease (What is coronary artery disease?), panic attack on Jun 26, 2008 from GERMANY Additional patient health information: Female patient , weighting 141.1 lb, was diagnosed with type 2 diabetes mellitus and. Exubera dosage: . Patient was hospitalized.

5802215-4 | Lung Neoplasm
Adverse event was reported on Jun 26, 2008 by a Male patient taking Exubera (View Usage) (Dosage: Daily Dose:20mg-text:7mg (ac B); 6mg (ac L); 7mg (ac D)) was diagnosed with type 1 diabetes mellitus and. Location: UNITED STATES , weighting 182.1 lb, After Exubera was administered, patient had the following side effects: lung neoplasm. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), MULTI VITAMINS (View Multi-vitamins Review and Multi-vitamins Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5779435-0 | Blood Glucose Increased, Chest Discomfort, Dyspnoea, Rash Erythematous, Swelling, Weight Increased
on Jun 12, 2008 Female patient from UNITED STATES , weighting 170.4 lb, was diagnosed with type 2 diabetes mellitus, panic disorder (What is panic disorder?) and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, chest discomfort, dyspnoea, rash erythematous, swelling, weight increased. Exubera dosage: . During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), EFFEXOR (View Effexor Review and Effexor Label ), PLAVIX (View Plavix Review and Plavix Label ), LANTUS (View Lantus Review and Lantus Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5775918-8 | Haemodialysis
on Jun 06, 2008 Male patient from GERMANY , weighting 154.3 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: haemodialysis. Exubera dosage: . Patient was hospitalized.

5775576-2 | Coronary Artery Disease, Panic Attack
Patient was taking Exubera (View Usage). After Exubera was administered, patient had the following side effects: coronary artery disease (What is coronary artery disease?), panic attack on Jun 06, 2008 from GERMANY Additional patient health information: Female patient , weighting 141.1 lb, was diagnosed with type 2 diabetes mellitus and. Exubera dosage: . Patient was hospitalized.

5767673-2 | Blood Glucose Increased, Chest Discomfort, Dyspnoea, Rash Erythematous, Swelling, Weight Increased
Adverse event was reported on Jun 05, 2008 by a Female patient taking Exubera (View Usage) (Dosage: ) was diagnosed with type 2 diabetes mellitus, panic disorder (What is panic disorder?) and. Location: UNITED STATES , weighting 170.4 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, chest discomfort, dyspnoea, rash erythematous, swelling, weight increased. During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), EFFEXOR (View Effexor Review and Effexor Label ), PLAVIX (View Plavix Review and Plavix Label ), LANTUS (View Lantus Review and Lantus Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5765779-5 | Lung Neoplasm
on Jun 04, 2008 Male patient from UNITED STATES , weighting 182.1 lb, was diagnosed with type 1 diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: lung neoplasm. Exubera dosage: Daily Dose:20mg-text:ud: 1mg-1mg, 6mg, 6mg, 6mg-freq:frequency: Tid; Interval: Qd. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5761600-X | Blood Glucose Increased, Chest Discomfort, Dyspnoea, Rash Erythematous, Swelling, Weight Increased
on May 27, 2008 Female patient from UNITED STATES , weighting 170.4 lb, was diagnosed with type 2 diabetes mellitus, panic disorder (What is panic disorder?) and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: blood glucose increased, chest discomfort, dyspnoea, rash erythematous, swelling, weight increased. Exubera dosage: . During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), EFFEXOR (View Effexor Review and Effexor Label ), PLAVIX (View Plavix Review and Plavix Label ), LANTUS (View Lantus Review and Lantus Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5760423-5 | Lung Neoplasm
Patient was taking Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: lung neoplasm on May 28, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 182.1 lb, was diagnosed with type 1 diabetes mellitus and. Exubera dosage: Daily Dose:20mg-text:ud: 1mg-1mg, 6mg, 6mg, 6mg-freq:frequency: Tid; Interval: Qd. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5756239-6 | Lung Neoplasm
Adverse event was reported on May 22, 2008 by a Male patient taking Exubera (View Usage) (Dosage: Daily Dose:20mg-text:ud: 1mg-1mg, 6mg, 6mg, 6mg-freq:frequency: Tid; Interval: Qd) was diagnosed with type 1 diabetes mellitus and. Location: UNITED STATES , weighting 182.1 lb, Patient had the following side effects: lung neoplasm. During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), VITAMIN D (View Vitamin D Review and Vitamin D Label ).

5752821-0 | Blood Glucose Increased, Dyspnoea, Rash, Swelling, Weight Increased
on May 27, 2008 Female patient from UNITED STATES , weighting 170.4 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: blood glucose increased, dyspnoea, rash (What is rash?), swelling, weight increased. Exubera dosage: . During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), EFFEXOR (View Effexor Review and Effexor Label ), PLAVIX (View Plavix Review and Plavix Label ), LANTUS (View Lantus Review and Lantus Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5748342-1 |
on May 19, 2008 Male patient from UNITED STATES , weighting 210.1 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). . Exubera dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

5746767-1 | Neoplasm Malignant
Patient was taking Exubera (View Usage). Patient had the following side effects: neoplasm malignant on May 10, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 233.0 lb, was diagnosed with blood glucose increased and. Exubera dosage: .

5741024-1 | Glycosylated Haemoglobin Increased
Adverse event was reported on May 05, 2008 by a Female patient taking Exubera (View Usage) (Dosage: ) was diagnosed with diabetes mellitus inadequate control and. Location: UNITED STATES , weighting 164.0 lb, After Exubera was administered, patient had the following side effects: glycosylated haemoglobin increased. During the same period patient was treated with GLUCOPHAGE (View Glucophage Review and Glucophage Label ), GLUCOTROL (View Glucotrol Review and Glucotrol Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), LAMICTAL (View Lamictal Review and Lamictal Label ), FEC (View Fec Review and Fec Label ), PREMARIN (View Premarin Review and Premarin Label ), VYTORIN (View Vytorin Review and Vytorin Label ), KLOR CON (View Klor-con Review and Klor-con Label ).

5741015-0 | Blood Glucose Increased, Dyspnoea, Rash, Swelling, Weight Increased
on May 05, 2008 Female patient from UNITED STATES , weighting 170.4 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose increased, dyspnoea, rash (What is rash?), swelling, weight increased. Exubera dosage: . During the same period patient was treated with TRANXENE (View Tranxene Review and Tranxene Label ), EFFEXOR (View Effexor Review and Effexor Label ), PLAVIX (View Plavix Review and Plavix Label ), LANTUS (View Lantus Review and Lantus Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), CLONIDINE (View Clonidine Review and Clonidine Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5739413-4 | Cough, Diabetes Mellitus Inadequate Control, Dyspnoea, Hypoglycaemia, Malaise, Respiratory Disorder, Tachypnoea
on May 06, 2008 Female patient from BRAZIL , weighting 127.9 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: cough, diabetes mellitus inadequate control, dyspnoea, hypoglycaemia, malaise, respiratory disorder, tachypnoea. Exubera dosage: Daily Dose:5mg. During the same period patient was treated with LANTUS (Daily Dose:24i.u.) (View Lantus Review and Lantus Label ).

5736645-6 | Rash, Urticaria
Patient was taking Exubera (View Usage). After Exubera was administered, patient had the following side effects: rash (What is rash?), urticaria on May 07, 2008 from UNITED STATES Additional patient health information: Male patient , weighting 173.9 lb, was diagnosed with type 2 diabetes mellitus and. Exubera dosage: . During the same period patient was treated with STATINS (View Statins Review and Statins Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMARYL (View Amaryl Review and Amaryl Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5729135-8 | Renal Failure
Adverse event was reported on Apr 28, 2008 by a Male patient taking Exubera (View Usage) (Dosage: ) was diagnosed with diabetes mellitus, hypertension, blood cholesterol increased and. Location: UNITED STATES , weighting 185.4 lb, Patient experienced the following unwanted or unexpected effects: renal failure. During the same period patient was treated with VERAPAMIL (View Verapamil Review and Verapamil Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), LASIX (View Lasix Review and Lasix Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5729094-8 | Dyspnoea, Hypoglycaemia, Respiratory Disorder, Tachypnoea
on Apr 25, 2008 Female patient from BRAZIL , weighting 127.9 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). Patient had the following side effects: dyspnoea, hypoglycaemia, respiratory disorder, tachypnoea. Exubera dosage: Daily Dose:5mg. During the same period patient was treated with LANTUS (Daily Dose:24i.u.) (View Lantus Review and Lantus Label ).

5726715-0 | Rash, Urticaria
on Apr 24, 2008 Male patient from UNITED STATES , weighting 173.9 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: rash (What is rash?), urticaria. Exubera dosage: . During the same period patient was treated with STATINS (View Statins Review and Statins Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ), AMARYL (View Amaryl Review and Amaryl Label ), LIPITOR (View Lipitor Review and Lipitor Label ).

5705980-X | Dyspnoea, Hypoglycaemia, Respiratory Disorder, Tachypnoea
Patient was taking Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hypoglycaemia, respiratory disorder, tachypnoea on Apr 07, 2008 from BRAZIL Additional patient health information: Female patient , weighting 127.9 lb, was diagnosed with diabetes mellitus and. Exubera dosage: Daily Dose:4mg. During the same period patient was treated with LANTUS (Daily Dose:24i.u.) (View Lantus Review and Lantus Label ).

5704705-1 |
Adverse event was reported on Apr 02, 2008 by a Male patient taking Exubera (View Usage) (Dosage: ) was diagnosed with diabetes mellitus and. Location: UNITED STATES , weighting 210.1 lb, . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

5703638-4 | Depression, Insomnia, Joint Injury, Procedural Pain, Stress
on Mar 28, 2008 Male patient from UNITED STATES , weighting 210.1 lb, was diagnosed with diabetes mellitus and was treated with Exubera (View Usage). After Exubera was administered, patient had the following side effects: depression (What is depression?), insomnia, joint injury, procedural pain, stress (What is stress?). Exubera dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ALPRAZOLAM (View Alprazolam Review and Alprazolam Label ).

5649561-5 | Blood Glucose Decreased, Dyspnoea, Wheezing
on Feb 25, 2008 Female patient from UNITED STATES , weighting 212.1 lb, was diagnosed with type 2 diabetes mellitus and was treated with Exubera (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased, dyspnoea, wheezing. Exubera dosage: . During the same period patient was treated with BYETTA (View Byetta Review and Byetta Label ), ACTOS (Daily Dose:45mg) (View Actos Review and Actos Label ), ALPRAZOLAM (Daily Dose:3mg) (View Alprazolam Review and Alprazolam Label ), LEXAPRO (View Lexapro Review and Lexapro Label ), ECOTRIN (View Ecotrin Review and Ecotrin Label ), FOLTX (View Foltx Review and Foltx Label ), SYNTHROID (Daily Dose:50mcg) (View Synthroid Review and Synthroid Label ), PREMARIN (View Premarin Review and Premarin Label ).

5642130-2 | Cerebrovascular Accident
Patient was taking Exubera (View Usage). Patient had the following side effects: cerebrovascular accident on Feb 22, 2008 from UNITED STATES Additional patient health information: Female patient , weighting 190.0 lb, was diagnosed with diabetes mellitus and. Exubera dosage: . During the same period patient was treated with LASIX (View Lasix Review and Lasix Label ), WARFARIN SODIUM (Freq:2.5mg Qd;5mg Tuesday, Thursday, Saturday) (View Warfarin Sodium Review and Warfarin Sodium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), VYTORIN (Freq:10/40 Qd) (View Vytorin Review and Vytorin Label ), PROTONIX (View Protonix Review and Protonix Label ), MIRALAX (Freq:qd) (View Miralax Review and Miralax Label ), CELEXA (View Celexa Review and Celexa Label ). Patient was hospitalized.